Search Within

Sandra D Pezzulli

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. GDMT, Medicine (5)
  5. Gynecologic Medicine Service (5)
  6. Gynecology Disease Management Team (5)

More Groups

People
  1. Carol Aghajanian (5)
  2. David Spriggs (5)
  3. Paul Sabbatini (5)
  4. Alexia Iasonos (4)
  5. Martee Hensley (4)
  6. Jason Konner (3)

More People

Years
  1. 2011 (1)
  2. 2009 (1)
  3. 2008 (1)
  4. 2007 (1)
  5. 1998 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (1)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission
    Journal Article

    Diefenbach, C. S. M.; Gnjatic, S.; Sabbatini, P.; Aghajanian, C.; Hensley, M. L.; Spriggs, D. R.; Iasonos, A.; Lee, H.; Dupont, B.; Pezzulli, S.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase I study of CT-2584 in the treatment of advanced carcinoma
    Meeting Abstract

    Waltzman, R.; Pezzulli, S.; Anderson, K.; Singer, J.; Aghajanian, C.; Sabbatini, P.; Chen, Y.; Ulerio, G.; Goodrich, K.; Venkatraman, E.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save